Annaida Technologies In The Top 10 for the W.A. De Vigier Award!

After the Top 16 was announced by the W.A. De Vigier in March, now the Top 10 finalists for this year’s Award are published. The winners will be announced in early June!

We are particularly proud to see our portfolio company Annaida Technologies in the Top 10 and wish them and all the Top 10 Startups and Entrepreneurs, the very best for the last stage of this competition.

About the W. A. De Vigier Foundation

Since the foundation’s establishment in 1987, the goal of the W.A. de Vigier Foundation has been to actively invigorate business development and further provide direct financial support (à fonds perdu) to young people with innovative business ideas wishing to build performance and growth oriented businesses in Switzerland. The great track record of W.A. de Vigier Award winners is particularly notable in the Top 100 Swiss Startup ranking: The top spots are regularly occupied by previous W.A. de Vigier Foundation Award winners.

About HEMEX

HEMEX AG is a privately-owned Swiss investment and consulting company headquartered close to the Basel global life sciences hub, with its main focus to bring innovative drugs, medical devices and in vitro diagnostics to the market. HEMEX specializes in supporting early-stage start-ups, offering tailored solutions to accelerate the project into a successful and sustainable business. Additionally, HEMEX helps start-ups in their efforts to find non-dilutive and dilutive funding. More at https://hemex.eu/

LiVET Closes CHF 1.3 Million Seed Financing Round

Congratulations to LiVET for closing their seed financing round, led by a private investor, together with the Zentrum für Innovation und Digitalisierung Bernapark (ZID) and Zürcher Kantonalbank (ZKB) who back the start-up developing a rapid point-of-care diagnostic test for infectious diseases in horses.

LiVET is a Swiss start-up with a profound knowledge and expertise in molecular detection of microorganisms. Their rapid molecular point-of-care diagnostic tests provide early and accurate diagnosis of widespread diseases in horses such as strangles, herpes and influenza. Its newly developed technology can carry out tests quickly and precisely, without complicated sample purification. Infectious diseases are feared by veterinary clinics, horseriding competitions or during the transport of highly priced sport horses. Spreading contagious diseases can trigger the requirement to quarantine horses. This may even lead to a longer-duration lockdown in a sector that employs over 100’000 jobs and can cause damage of several hundred million Swiss Francs. Currently, LiVET is already running pilot trials with several horse clinics across the globe.

LiVET gained significant international traction and has been selected among the 20 top animal health startups to present their rapid on-site diagnostic solution in front of the industry’s influential figures and investors.

Press Release Seed LiVET

 

Several HEMEX team members have a proven track record of working for many years in the animal health industry, supporting the development of veterinary medicines and innovative new technologies, which is why we have been supporting LiVET since its incorporation.

 

Swiss Innovation Challenge – Digital kick-off!

2020 Swiss Innovation Challenge – the traditional networking kick-off event for the SIC was held virtually due to COVID-19 crisis on April 2, 2020!

Numerous entrepreneurs from Switzerland and other European countries attended the online kick-off for this years challenge. 100 start-ups from all categories will be admitted to the first pitch, but only 50 are eligible for the next round. The selection process consists of 3 pitching cycles in total. The whole challenge is supported by a mentoring- and coaching program.

The winners of the SIC will be announced at the award ceremony on November 26th, 2020.

The SIC was launched in 2014 by Baselland Chamber of Commerce, the University of Applied Sciences Northwestern Switzerland (FHNW) and the Bank of Baselland (BLKB).

HEMEX will support this 6th edition with a special prize in the “Life Sciences” category and take place in the jury.

HEMEX is a Bench-to-Market Life Science Provider. We support life science start-ups with a wide range of expertise, either in-house or via our network of pre-qualified experts, laboratories, CMOs, warehouses, logistic partners and affiliates. Our development team supports with Quality Assurance, Medical and Regulatory Affairs, Clinical Operations, Biostatistics, Medical Writing and eSubmissions.

 

Congratulations to our portfolio company Inura Medical AG

Inura Medical AG is admitted to participate at the 2020 >>venture>> competition!

Inura Medical AG is a Swiss start-up company focused on the development of re-purposed urological products that combine a medical technology consisting of an urethral suppository and a pharmaceutical agent. Its first product offers a rescue therapy to two highly prevalent and disabling health disorders: overactive bladder (OAB) and nocturia. The Company’s innovative, patented proprietary formulation technology is designed to facilitate the effective penetration of drugs through the urethral mucosal lining and bladder to reach targeted tissues. In January this year, Inura Medical AG has moved into the HEMEX INCUBATOR in Liestal, Switzerland where Inura receives support by our dedicated team in the clinical and regulatory development.

>>venture>>  

For the 2020 edition >>venture>> will be awarding a total of CHF 510,000 thanks to the generous support of sponsors. Start-ups will be competing under 5 verticals: Health & Nutrition, Industrials & Engineering, ICT, Retail & Consumer Services, and Finance & Insurance. The program is supported by workshops and allows access to a large pool of mentors and coaches.

Hemex Incubator

Hemex offers a 6-step incubation program where start-ups are coached all the way on their journey from “green to gold”. Start-ups can enter the program at any stage and benefit from tailored solutions. Hemex combines development and fundraising skills and offers a distinctive advantage when interacting with the investor community.

 

The Top 16 for the W.A. De Vigier Award Are Announced!

Gora Conley Annaida presenting for deVigier 2020 swiss starups awards

After the Top 60 selection day for the W.A. De Vigier Award on February. Today the Top 16 were published. In the coming weeks the W.A. de Vigier jury will select the Top 10, based on expert reports, business plans, assessments and another presentation the winners will be announced at our Award Ceremony on June 3, 2020.

We are particularly proud to see Annaida, LiVET and Juvabis being in the Top16!

Top 16 Swiss startups for DeVigier Award 2020

About the W. A. De Vigier Foundation

Since the foundation’s establishment in 1987, the goal of the W.A. de Vigier Foundation has been to actively invigorate business development and further provide direct financial support (à fonds perdu) to young people with innovative business ideas wishing to build performance and growth oriented businesses in Switzerland.

The great track record of W.A. de Vigier Award winners is particularly notable in the Top 100 Swiss Startup ranking: The top spots are regularly occupied by previous W.A. de Vigier Foundation Award winners.

More information: De Vigier website

Swiss Innovation Challenge – 2020 Open Call

Tolremo is a winner of Swiss innovation challenge for startups 2019

Startups and SMEs are invited to participate in the Swiss Innovation Challenge, organized by the Chamber of Commerce of Baselland, the University of Applied Sciences and Arts Northwestern Switzerland (FHNW) and the Basellandschaftliche Kantonalbank (BLKB), and present their outstanding innovations and business ideas to the jury. Applications are open until 31st March.

In order to support the development and implementation of innovative business ideas, the Swiss Innovation Challenge offers attractive awards and a unique 8-month acceleration program. All the while building the path towards recognition and business success, 100 selected participants will benefit from a comprehensive support platform with individual coaching, tailored education and extensive mentoring, as well as get access to sponsors and potential business partners. Start-ups and SMEs will receive expert support to accelerate their innovative projects and face the competition through three elimination rounds. In addition to the main award, participants can win special prizes in the fields of “Globalization”, “Life Sciences” and “Construction”.

 

tolremo is a winner of Swiss innovation challenge for startups 2019At HEMEX, we are always looking for ways to help unlock new possibilities and support innovations that drive progress. That is why we are very pleased to have become a partner of the 6th edition of Swiss Innovation Challenge. HEMEX will support the competition with a special prize in the “Life Sciences” category, and take place in the jury.

To date, the Swiss Innovation Challenge has promoted more than 500 innovation projects.

For online registration, follow the link below:

http://www.swissinnovationchallenge.ch

Swiss startup LiVET gains international attention

Tim Pfister of LiVET presenting among 20 top animal health startups at Animal Health Investment Europe 2020

Recognized by the premium investment forum – Animal Health Investment Europe 2020 – LiVET has been selected among 20 top animal health startups to present their rapid on-site diagnostic solution in front of the industry’s most influential figures and investors.

LiVET is a Swiss startup with a profound knowledge and expertise in molecular detection of microorganisms. Their rapid molecular point-of-care diagnostic tests provide early and correct diagnosis of infectious diseases in animals. Lab-quality results are guaranteed within 30 min, for up to 16 samples at once, which allows for immediate and specific treatment. By bringing the application of specialized laboratories closer to the patients they strive to increase the quality of animal health care. Working closely with LiVET our team at Hemex supported them in further developing their marketing efforts as well as to improve their odds in fundraising process by building a compelling visual presentation for their London pitch.

Tim Pfister of LiVET presenting among 20 top animal health startups at Animal Health Investment Europe 2020 Tim Pfister of LiVET presenting among 20 top animal health startups at Animal Health Investment Europe 2020As the animal health industry experiences a shift towards the detection and prevention of disease rather than simply the treatment of it, the Animal Health Investment Europe 2020 forum focuses on presenting innovation in nutritional health, data analytics, sensors and diagnostics. While showcasing the most exciting investment opportunities in animal health and nutrition the forum is also connecting those businesses with financial investors and strategic corporate partners. Bringing together academics, investors, startups and industry leaders animal health and nutrition companies are given a great opportunity to learn from and adapt to the impacts of disruptive technologies as well as possibility to meet face-to-face with decision makers from the full spectrum of the animal pharma and nutritional health industry.

W. A. De Vigier Foundation “TOP 60” Selection Day

W. A. De Vigier Awards selection day for 60 Swiss startups

60 startups pitched their ideas on February 13 at the 2020 Selection Day. It was a full house and we were once again impressed with what Switzerland has to offer when it comes to innovation and leadership! We’ll let you know in the middle of March who goes on to the Top 16. The winners will be announced at our Award Ceremony on June 3, 2020.

About the W. A. de Vigier Foundation

Since the foundation’s establishment in 1987, the goal of the W.A. de Vigier Foundation has been to actively invigorate business development and further provide direct financial support (à fonds perdu) to young people with innovative business ideas wishing to build performance and growth oriented businesses in Switzerland.

In the past 29 years, the foundation has distributed over CHF 11 million of seed capital. The results are about 84 ourishing startups, successful IPOs, multiple company exits and above all, many newly created jobs.

The great track record of W.A. de Vigier Award winners is particularly notable in the Top 100 Swiss Startup ranking: The top spots are regularly occupied by previous W.A. de Vigier Foundation Award winners.

About Hemex

Hemex supports start-ups as well as established medical device, biotech and pharmaceutical companies with a wide range of expertise, either in-house or via their network of dedicated partners and affiliates. Hemex’ experts have several decades of combined experience in the pharmaceutical and medical technology industry with pivotal contributions to the development and approval of innovative products. Hemex supports companies in their interactions with the investor community and also offers interesting collaboration programs, including public and private seed funding. 

More pictures of the event can be found here

Startups, apply for the W.A. de Vigier Award now!

W. A. de Vigier swiss startup award winners 2019

The W.A. de Vigier Award is the oldest and highest endowed prize for startups in Switzerland, giving away five awards of CHF 100’000 each. Applications are open until January 6th.

Since 1989, the foundation has distributed over CHF 11 million of seed money, resulting in more than 90 thriving Swiss startups, successful IPOs, multiple company exits and many newly created jobs. 

This year our portfolio company Sleepiz AG – with their revolutionary sleep disorder-screening device – was announced as one of the award winners.

For online registration follow the link below:

https://devigier.chW. A. de Vigier swiss startup award winners 2019

 

DayOne supports 6 digital health startups

DayOne accelerator program for digital health startups

Following their hard work in developing innovative solutions that promote the health of children and young people, 6 digital health startups:Zoundream, Haako, Rekonas (eTomo), Wello Health, Virtual Doctors and Nutrix, were selected for DayOne Accelerator program, which is managed by BaselArea.swiss.

At HEMEX, we are especially proud of our partners from Haako, Moritz Dietsche and Marko Kocic. Their mobile solution Breathe helps families with children affected by asthma to better manage their conditions.

To read more about the DayOne Accelerator and participants, please click here.